drugset / Trial / NCT01002079
Drug-Drug Interaction Study With Rifampin
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to determine if the concomitant administration of rifampin with BMS-708163 will affect the Pharmacokinetics of BMS-708163 and to assess safety and tolerability of co-administration BMS-708163 and rifampin
Timeline
- Start
- 2010-08
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avagacestat | Small molecule | 125 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |